Two-year outcomes from the MitrAl ValvE RepaIr Clinical (MAVERIC) trial: a novel percutaneous treatment of functional mitral regurgitation.
Patterson T, Gregson J, Erglis A, Joseph J, Rajani R, Wilson K, Prendergast B, Worthley S, Hildick-Smith D, Rafter T, Whelan A, De Marco F, Horrigan M, Redwood SR.
Patterson T, et al. Among authors: redwood sr.
Eur J Heart Fail. 2021 Oct;23(10):1775-1783. doi: 10.1002/ejhf.2321. Epub 2021 Aug 30.
Eur J Heart Fail. 2021.
PMID: 34363280
Free article.
Clinical Trial.